Ben Harshbarger
Algemeen Adviseur bij ASTRIA THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Ben Harshbarger
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
79
| Public Company | Pharmaceuticals: Major | 79 |
| Subsidiary | Pharmaceuticals: Major | 24 | |
| Extinct | Pharmaceuticals: Major | 23 | |
| Holding Company | Pharmaceuticals: Major | 22 | |
| Public Company | Pharmaceuticals: Major | 21 | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA.
18
| Private Company | Miscellaneous Commercial Services | 18 |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA.
16
| Subsidiary | Medical Specialties | 16 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ben Harshbarger via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director of Finance/CFO Human Resources Officer Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Chairman Director/Board Member Director of Finance/CFO Chief Operating Officer Director of Finance/CFO | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Compliance Officer Sales & Marketing | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director of Finance/CFO Director/Board Member Founder | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| Georgetown University Law Center | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| CELGENE | Biotechnology | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
| KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Compliance Officer | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| TREVENA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| IMMUNOGEN, INC. | Biotechnology | Director of Finance/CFO Human Resources Officer General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | General Counsel President Corporate Officer/Principal | |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | President Comptroller/Controller/Auditor Corporate Officer/Principal | |
| Boston University | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member Director/Board Member | |
| VERASTEM, INC. | Biotechnology | General Counsel Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Human Resources Officer | |
| NS WIND DOWN CO., INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | President Sales & Marketing | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Graduate Degree | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| FATE THERAPEUTICS, INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Chairman Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Ierland | 3 |
| Verenigd Koninkrijk | 3 |
| Israël | 2 |
Sectoraal
| Health Technology | 36 |
| Consumer Services | 12 |
| Finance | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 448 |
| Corporate Officer/Principal | 257 |
| Independent Dir/Board Member | 180 |
| Undergraduate Degree | 91 |
| Chairman | 91 |
Sterkste connecties
| Insiders | |
|---|---|
| William Young | 32 |
| Lonnie Moulder | 31 |
| John Thomas | 30 |
| Mark Corrigan | 29 |
| Hans-Peter Hasler | 28 |
| Faheem Hasnain | 27 |
| Alison Lawton | 25 |
| Marc Beer | 25 |
| Gregg Lapointe | 25 |
| Sylvie Grégoire | 25 |
| William Rastetter | 24 |
| Anne VanLent | 23 |
| Burt Adelman | 23 |
| Peter Kellogg | 21 |
| Tamara Joseph | 19 |
- Beurs
- Insiders
- Ben Harshbarger
- Bedrijfsconnecties
